Zeiss Medical Technology announced that it received FDA 510(k) clearance for its MTLawton disposable bipolar forceps.
Jena, Germany-based Zeiss designed the forceps with a special copper-base alloy. MTLawton potentially reduces tissue adhesion and subsequent charring during the dissection of tissue.
The system also features an extended shaft that helps the forceps reduce visual restrictions in the surgical field. This helps surgeons with efficiency during electrosurgical procedures. MTLawton came out of a close collaboration with neurosurgeon Dr. Michael T. Lawton, according to a news release.
“The MTLawton Disposable Bipolar Forceps are a real advance in electrosurgery over aluminum forceps. Our copper-base alloy has superior thermal conduction to improve cautery-based hemostasis and reduce tissue adhesion,” said Lawton, president and CEO of the Barrow Neurological Institute in Phoenix and chair of its Department of Neurosurgery.
Added Lawton: “I take these MTLawton bipolars into battle with all my difficult arteriovenous malformations, and they give me a noticeable advantage.”
According to Zeiss, high heat can cause electrosurgical instruments to stick to the tissue when coagulating it. MT Lawton enables non-stick technology through the copper-base alloy. The improved material conducts heat away from the silver-plated tips faster. This potentially reduces tissue adhesion and charring.
MTLawton also allows for a clear view of the cauterization area, even in narrow and deep cavities. The robust copper-based materials also allow for the more efficient handling of tissue, Ziess says.
“With the acquisition of Kogent Surgical in April 2022, ZEISS has expanded its range of surgical solutions for microsurgery. We are pleased to be able to introduce the first surgical instrument from this acquisition to the market with FDA approval for MTLawton,” said Dr. Markus Weber, CEO of Carl Zeiss Meditec.